1. K. Boda, Dissolution Failure Investigation, Agilent Technologies; https://studylib.net/doc/18624684/dissolution-failure-investigation.
2. S. Singh, K. V. R. Rao, K. Venugopal, and R. Manikandan, Pharm. Tech., 26(4), 36 – 58 (2002); https://alfresco-staticfiles.s3.amazonaws.com/alfresco-images/pharma/2014/08/22/3257ca7d-8bd7-4b99-88a8-c7aaa129b3b7/article-14096.pdf [https://cdn.sanity.io/files/0vv8moc6/pharmtech/8272b8313e6cdc3b1358c3cfa7709d52ebba684b.pdf/article-14096.pdf].
3. J. J. Dressman and J. Kramer (eds.), Pharmaceutical Dissolution Testing, CRC Press, Boca Raton (2005); https://doi.org/10.1201/9780849359170.
4. K. Saeio, Y. Pongpaibul, H. Viernstein, and S. Okokogi, Sci. Pharm., 75, 147 – 163 (2007); https://www.mdpi.com/2218-0532/75/4/147/pdf.
5. A. K. Tiwary, B. Sapra, and S. Jain, “Dissolution,” in: Preclinical Development Handbook: ADME and Biopharmaceutical Properties, Shayne Cox Gad (ed.), John Wiley & Sons, Inc., Hoboken, New Jersey (2008), pp. 483 – 544; https://onlinelibrary.wiley.com/doi/book/10.1002/9780470249031.